# A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

> **NCT05718492** · NA · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 100 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** digital subtraction angiography.
- **DRUG:** FOLFOX (oxaliplatin , leucovorin , fluorouracil , and fluorouracil )

## Key facts

- **NCT ID:** NCT05718492
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-18
- **Primary completion:** 2025-10-18
- **Final completion:** 2026-10-18
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05718492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05718492, "A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05718492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*